HWAM
AKBA icon

Hennion & Walsh Asset Management’s Akebia Therapeutics AKBA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$957K Buy
839,729
+206,476
+33% +$246K 0.03% 573
2026
Q1 		$880K Buy
633,253
+134,292
+27% +$185K 0.03% 546
2025
Q4 		$803K Buy
+498,961
New +$1.04M 0.03% 577

Other funds holding AKBA

SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
IWN
Independent Wealth Network Urbandale, Iowa $393M AUM 30.08% 1-Year Est. Return
LPT
Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Hennion & Walsh Asset Management's AKBA Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Akebia Therapeutics (AKBA) stake by 33% in Q2 2026, buying an estimated $246K and bringing the position to 839,729 shares worth $957K. The position accounts for 0.03% of the portfolio, ranked #573.

Hennion & Walsh Asset Management first reported a position in AKBA in Q4 2025 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Hennion & Walsh Asset Management held 839,729 shares of Akebia Therapeutics worth $957K as of Q2 2026.
  • Hennion & Walsh Asset Management bought 206,476 Akebia Therapeutics shares in Q2 2026, an estimated $246K.
  • Akebia Therapeutics made up 0.03% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #573 holding.
  • Hennion & Walsh Asset Management first reported a position in Akebia Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.